Company Filing History:
13 out of 350 
2 out of 1,217 
2 out of 3,685 
Years Active: 1986-2007
Title: **Anita H. Lewin: Pioneering Innovations in Neuropharmacology**
Introduction
Anita H. Lewin, based in Chapel Hill, North Carolina, is a prominent inventor recognized for her significant contributions to the field of neuropharmacology. With a remarkable portfolio of 16 patents, her research focuses primarily on the development of novel therapeutic compounds that target cocaine receptors and other neurotransmitter systems in the brain.
Latest Patents
Lewin's latest patents revolve around cocaine receptor binding ligands, which represent a groundbreaking class of compounds with high binding specificity and activity. These compounds are particularly valuable in their radiolabeled form, allowing them to bind to cocaine receptors for biochemical assays and imaging techniques. The imaging capabilities provided by these ligands are instrumental in determining effective doses of new drug candidates for various human populations. Additionally, the slow onset and long-lasting effects of these compounds make them ideal candidates for therapeutic applications, such as substitute medications for psychostimulant abuse. Remarkably, some of these ligands also show potential in treating conditions such as Parkinson's Disease and depression, due to their inhibitory effects on monoamine transporters.
Career Highlights
Throughout her career, Anita H. Lewin has held significant roles at prestigious institutions. Notably, she worked at the Research Triangle Institute and contributed to projects with the United States of America as represented by the Department of Health. Her expertise and innovative approach have positioned her as a leading figure in neuropharmacological research.
Collaborations
Anita has collaborated with esteemed colleagues including Frank Ivy Carroll and Philip Abraham. These collaborations have fostered groundbreaking advancements in the development of new therapeutic agents, enhancing the understanding and treatment of various neuropsychiatric disorders.
Conclusion
Anita H. Lewin's innovative work in the area of cocaine receptor binding ligands exemplifies her dedication to improving therapeutic outcomes for individuals battling substance abuse and neurodegenerative diseases. Her patents not only reflect her extensive research capabilities but also establish her as a key inventor in the field of neuropharmacology, paving the way for future innovations.